click below
click below
Normal Size Small Size show me how
Cardiology Pathology
for BOD
Question | Answer |
---|---|
Left Anterior Descending Artery Supplies... | Anterior Wall & Some Septal Wall (Has "Diagonal Branches") |
Left Circumflex Artery Supplies... | Lateral Wall (Has "Marginal Branches") |
Right Coronary Artery Supplies... | Inferior Wall (Usually PDA off of it, which Supplies Infra-Septal and Inferior Wall) |
Heart Blocks (1st, 2nd, 3rd Degree) | 1st Degree: Consistent PR delay (>200 ms), No Skipped Beats. 2nd Degree: Increasingly lengthen PR w/ occasional PVC. 3rd Degree: Junctional (narrow) escape rhythm with complete AV. block |
Alpha Receptors | Epi > NE (no isopreternol). Vasoconstriction, Mydriasis, Splenic Contraction. Gq --> PL-C --> DAG + IP3. DAG--> PKC + MAPK (Vasoconstrict, ^BP). IP3 --> Ca from SR (^ Cardiocontractility). |
Beta Receptors | Iso > Epi > NE. Cardiostimulation, Bronchodilation, Vasodilation, Metabolic Acidosis. Gs --> Adenylyl Cyclase --> cAMP --> PKA --> Ca from SR --> Contractility |
Epinepherine | Alpha Receptors: Vasoconstriction Beta Receptors: Vasodilation |
Norepinepherine | Alpha Receptors (Mostly): Vasoconstriction Beta-1 Receptors (Cardiac): Cardiostimulation |
Ispopreternol | Beta Receptors: Vasodilation and cardiostimulation |
Ergotoxin | Blocks NE's Vasoconstriction (alpha) Blocks Epi's Vasoconstriction (alpha) Does NOT block Epi's Vasodlation (Beta) Alpha Blocker (The First!) |
Dichloroisopreternol | Beta Blocker (The first!) |
Dopamine | Inotropine (Similar to NE) Increase force of contraction Vasodilates renal arteries (but alpha effects & vasoconstriction at high doses) Indicated for shock with oliguria (increase CO via Beta Receptors & Increase renal blood flow via DA-ergic effects) |
Dobutamine | (+) isomer: Beta-1 Agonist + Alpha-1 Antagonist (-) isomer: Alpha-1 agonist For: Short term for CHF, MI (increase CO, SV w/o HR increase) |
Blood Vessels | Alpha-1 & Alpha-2 (Constrict to ^^BP). Beta-2 (Dilate in Skeletal muscle arterioles) |
Bronchi | Alpha-1 (Constrict). Beta-2 (Relaxes) |
Heart | Beta-1 & Beta-2 (increase HR, increase contractility). Target for beta-blockers! |
Nerve Endings | Alpha-2 (neg feedback to lower NE Release). Beta-1 & Beta-2 (on nerve endings. Increase NE Release) |
Mast Cells | Beta-2 (less histamine release) |
Second Messengers for Alpha-1, Alpha-2, Beta-1, Beta-2 Receptors | A1 (IP3 + DAG). A2 (less cAMP). B1+B2 (more cAMP). |
Ritodrine | B2 agonist. Delays uterine contraction att erm. |
Salbutamol | B2 agonist. For asthma |
Methoxamine & ****PHENYLEPHRINE***** | A1 agonist (vasoconstriction) |
Alpha-Methylnorepinepherine & Clonidine | Alpha-2 agonist (neg feedback to stop vasoconstriction) |
Butoxamine | B2 antagonist |
Labetolol & Metoprolol | B1 antagonist |
***Propanolol*** | B1 & B2 antagonist |
Yohimbine | A2 antagonist |
Prazosin | A1 antagonist (for HTN) |
***Phentolamine*** | Short-acting A1/A2 antagonist (for shock) |
***Phenoxybenzamine*** | Long-Acting A1 & A2 antagonist (for shock) |
Cocaine | Sympathomimetic. Blocks NET (more NE in synapse). Increase O2 demand (A + B adrenergic effect) w/ less O2 delivery. Result: ischemia, infarction, arrhythmia. Chronic: dilated or hypertrophic cardiomyopathy, atherosclerosis, myocarditis, necrosis. |
Platelet Aggregation | Expose subendothelial Matrix. Thromboxane A2 + ADP recruit + activate platelets to form plug). |
Anti-Platelet Drug Targets | Platelet Surface ADP Receptor P2Y12 (CLOPIDOGREL & PRASUGREL) & GPIIB/IIIa Receptors (ABCIXIMAB). Platelete dense granules: ThrombaxaneA2 (ASPIRIN via Cyclooxygenase inhibition. Irreversible) & ADP (CLOPIDOGREL + PRASUGREL). |
Endothelial Cell Drug Targets (ANti-Clotting) | |
***Aspirin*** (Acetyl Salicyclic Acid) | Acetylates serine in COX-1. Irreversible inhibition. (Cannot become TxA2 which normally causes vasoconstriction and platelet agg). Toxicities: GI discomfort, bleeding, antiinflamm, Hypercapnia, Glucose intolerance, poison (reps alk, met acidosis, RD) |
***Clopidogrel*** (Plavix) | P2Y12 Antagonist. Prodrug (CYP2C19 activates). (Omeprazole is a CYP2C19 inhibitor). Used to prevent occlusion after stunting coronary vessels. |
***Prasugrel*** (Effient) | P2Y12 antagonist. Prodrug. MOre potent than plavix, more bleeding. Does not use CYP2C19, but DOES use Cyp3A5 + 2B6. |
Ticagrelol (Brilanta) | Direct (no CYP450) reversible inhibitor of P2Y12 |
Abciximab, Tirofiban, Eptifibatide, Lamifiban | GPIIb/IIIa antagonist (block receptor). Inhibit platelet aggregation BUT risk intrinsic platelet activation & thrmbocytopenia (low platelet count). Used, bu limited. |
Anticoagulants (note, different from antiplatet, these are anti-clotting) | Normally: tissue injury --> TF expressed, Phospholipid complex forms, Activates thrombin, Fibrin polymerization and clot formation |
Pro-coagulation from Thrombin (IIa) | ADP, TXA2, Va, VIIa, XIa, TAFI (thrombin-activated thrombolysis inhibitor) |
Anti-coagulation from Thrombin (IIa) | Prostocyclin, NO, tPA, Protein C+S (activate by IIa will inactivate Va, VIIIa) |
Heparin (Anticoagulant) | Inactivates ACTIVE clotting factors oof INTRINSIC pathway. WOrks by accelerating ATIII 1000x |
HIT | Heparin-Induced Thrombocytopenia: combo of bleeding AND thrombosis (30% mortality): activated platelets, removed by spleen macrophages (thrombocytopenia). Plaetelets also procoaglunant (thrombosis). Treat with thrombin inhibitors. |
LMWH (***enoxaprin*** dalteparin, ___parin) | Low molecular weight heparin: more predictable effects, can give subQ, more bioavailable, longer half life, less HIT, less osteoporosis. does NOT inhibit IIa. |
Thrombin Inhibitors (***Hirudin (leech derivative), Lepirudin, Argatroban, Bivalirdivin, **Rivaroxaban***(oral), ***Apixaban*** (oral) | Use for HIT (inactivates soluble and clot-bound IIa. WOrks if ATIII is deficient). |
Warfarin | Oral anticoag. Inhibits FORMATION of active (acts @ IX, X, II). Prevents gamma carboxylation by inhib. vit K epoxide reductase. Takes ~1 week to kick in (circ clotting factors long 1/2 life). Monitor INR (2-3). CYP2C9. More vit K may lower INR. Teratogen. |
Fibrinolysis (tPA, streptokinase, Reteplase, Tenecteplase) | tPA from endothelial cells, activates plasmin to degrade clot (more D-dimer in blood). Give for acute MI, thrombotic stroke, arterial thromboses, PE, DVTs, occlude catheters and shunts. Bleeding risk! Streptokinase: risk allergic rxn. Not fibrin-specific |
Rose Criteria (is pain cardiac?) | 1. Substernal Chest Pain 2. Temporal Relation to Stimulus (Exercise/Stress) 3. Relieved with discontinuation of stimulus 4. Relieved with Nitrates |
Virchow's Triad | 1. Hypercoaguability 2. Hemodynamic Changes (stasis/turbulence) 3. Endothelial cell injury/Dysfunction.......THROMBUS!!! |
Risk Factors (For Pretty much Everything) | Male, Old, Smoker, HTN, Dislipidemia, Atherosclerosis, Family History |
AAA (Abdominal Aortic Aneurism) | Saccular (one side) + Fusiform (all the way around. True (ALL layers) vs. False (Confined by adventitia but can still easily rupture) |
Vasculitis | High ESR, High CRP, GIant cell arteritis, Sup temporal artery, common in elderly, often unilateral. Can go blind. Multinucleited giant cells. |
Large Vessel Vasculitis | Giant cell arteritis if >50 YO, Takayasu if < 50 YO |
Medium Vessel Vasculitis | Polyarteritis Nodosa (w/o MCLN) Lawasaki (w/ MCLN) (MCLN = mucocutaneous lymph node syndrome) |
Small Vessel Vasculitis | Many! Immune complexes in vessels or paucity of vasc IgG |
ST Depression | More global ischemia, cormobidities, coronary disease, hypertension, hyperlipidemia. A chronic thing. |
Angina: General Treatment Strategies | 1. Nitrates 2. Calcium Channel BLockers 3. Beta Blockers |
Nitrates (Glyceryl Trinitrate/Nitroglycerine) | Venous capicitanse (more preload, less O2 demand). Release NO in vasc smooth muscle cells. Kidney excretion. Relzx blood vessel. Dosage! (vein-->arteries). Met by mito lad dehy. NO --> cGMP --> relax smooth muscle |
Calcium Channel Blockers ***Verapamil***, ***NIfedipine***, Dilitiazem | Inhibit calcium entry. Verapiml + Dilitiazem suppress conduction (@ nodes) so less HR, more vasodilation, less contractility. Nifedipine, Nicardapine, Minodipine do NOT have effect on Conduction (vasodilator, less contractility). |
Beta Blockers | Less contractility, less renin/angiotensein so lowers BP, anti-arrhythmic, less exercise tachycardia |
1st Generation (Blanket) Beta Blockers | ***Propanolol*** (etc) |
2nd Generation (B1) Beta Blockers (Cardioselective) | Atenolol, ***Metoprolol*** etc |
3rd Generation (Vasodilating) Beta Blockers | Pindolol, ***Carvedilol*** etc |
Mixed alpha/beta blocers | Labetalol |
9 min half life beta blocker | Esmolol (to lower BP in ER) |
Giant Cell Temporal Vasculitis | Large Vessel. Granulomatous vasculitis of aorta and extra cranial branches of carotid. Patients >50. May lead to blindness. Associated w/ polymyalgia rheumatica |
Takyatsu Arteritis | Involves aortic arch and branches by granuloomatous arterities. Thickened intima. Female. Patients < 50 |
Polyarteritis Nodosa | Lesions of dif ages. 30% associated w/ HepB. Necrotizing inflammation w/o glomerulnephritis. Nodules on arterial wall, skin, viscera. Immune complex disease. Fibrinoid necrosis |
Kawasaki Disease | Kids <4 yo, most common acquired heart disease in children. smooth muscle in arterial wall. Arteritis associated w/ MLNS |
Wegener Granulomatosis | Granulomatous inflam. Resp tract, kidney , sinus, nasal mucosas. Necrotizing glomeruonephritis common. C-ANCA (anti-neutrophil cytoplasmic antibiodies) Low Ig. |
Churg-Strauss Syndrome | Eosinophilia, Asthma, Granulomas. Glomerunophritis. p-ENCA |
Microscopic Polyangitis/arteritis | Lesions of the same age. Nec glomeruonephritis common. Pulm capillaries involved. C-ANCA. Leads to hemorrhage. |
Granulmoatous Vasculitis (Temporal Arteritis) | Intima Prolif, breaks in elastic stain. Biopsy need not be (+), elevated SED rate and CRP |
Buerger Disease | Thromboangitis obliterans (in extremeties. Ven thromboses. With Tobacco!) |
Rheumatic Fever | Pharyngitis, Skin absess (impetigo), group A strep pharyngitis precedes it. Antigen-mimic (M protein). Give prophylatic penicillin |
Jones Criteria | 2 Major or 1 Major + 2 Minor. Required: Evidence of Strep. Major: Carditis, Polyarteritis, Chorea, Erythema Marginatum, SubQ nodules. Minor: Fever, Arthralgia, Previous Rheum fever/heart disease, ESR up, CRP up, leukocytosis, PR interval up (heart blo |
Fibrinous Pericarditis | From: End Stage Renal Disease, MI, Dressler's Syndrome (after MI), Radiation Pericarditis, Virus, Trauma, Drugs. UREMIA. "Bread & Butter." See fat, organization, fibrin (pink/amorphous) |
Fibrous Pericarditis | Stiff, can't contract. TB, fungal, pericarditis, tumor, radiation, no-resolving fibrillin. Fibroblastic prolif. Create brididges pericardium to epicardium. KUSMALL sign: JVD |
4 Factors Influencing Cardiac Performance | 1. Preload (venous return) 2. Afterload (TPR) 3. Cotnractility 4. HR |
Digitalis, Digoxin (longer), OUabain (shorter) | More contractility vía more intracellular sodium (inhibit the na/k atpase. Stops calcium extrusion. so more pumping. |
DAD | Delayed after depolarization...more contractility, V. tach (toxicity of digitalis). |
Beta Blockers in CHF | Metoprolol - B1 selective Carvedilol - Non selective |
Systolic HF | "Fat and Short" P(V) curve |
Diastolic HF | "Tall and Skinny" P(V) Curve |
FACES | Heart failure symptoms: Fatigue, Angina, Congestion (Chest), Edema, SOB |
NYHA Classification | I: Mid II Mild (slight limitation III Moderate (marekd limitation) IV: severe |
ACC/AHA Classification: | A: High risk B: Asymptomatic LV dysfunction C: Past/current HF Sx D: End Stage HF |
EAD (early after depolarizations) | Phase 2: prolonged or Phase 3 prolonged. Can mediate torsade de Pointes (polymorphic VT) |
DAD (delayed after depolarization) | Impaired calcium handling (Na/Ca exchanger up, then depolarizing current). Occurs w/ digitalis and idiopathic c VTs. Sensitive to adenosine, Calcium channel blockers, beta blockade. |
Class 1 Anti-Arrhythmics | Block Entry of Na (Phase 0). 1b (RAPID i.e. LIDOCAINE). 1a (med ie QUINIDINE). 1c (longer ie econide and flecanide). |
Class 2 Anti-Arrhythmics | Beta Blockers -Main effect on L-type calcium channels and If phase 4 in nodal cells. PROPANOLOL: anti-arrhythmic, inhibits exercise tachycardia, alleviates angina, lowers renin. Use for increased sympathetic activity. |
Class 3 Anti-Arrhythmics | K Blockers (slow depolarization) Amioderone, Sotalol, Bretylium. Prolong repolarization (may see EADs). Also photosensitivity with AMiderone. |
Class 4 Anti-Arrhythmics | Ca Channel Blockers. 4a: L-type Ca block. Shorten repolarization (verapamil, dilitiazem). Depress phase 0 in SA cells, shorten plateau. 4B: K channel openers (ADENOSINE). SLOWING of AV conduction. DO NOT USE IN ASTHMA. for paroxysmal supra vent. tach. |
Automaticity Arrhythmia? | Use Beta Blocker, Calcium Channel Blocker |
Triggered Arrhythmia (EADs/DAD's)? | Use Beta blockers, Calcium Channel Blockers |
Conduction (reentry) Arrythmias? | Sodium and Calcium blockers. |
Imaging | X-ray, Cath, Nuclear, Echo, CTA, MR |